CervoMed Inc. Preferred Stock Dividends, Income Statement Impact
CervoMed Inc. (CRVO) reported Preferred Stock Dividends, Income Statement Impact of $8.17 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2018-11-13
- CervoMed Inc. preferred stock dividends, income statement impact for the quarter ending 2018-09-30 was $0.00.
- CervoMed Inc. preferred stock dividends, income statement impact for the quarter ending 2013-12-31 was $0.00.
- CervoMed Inc. preferred stock dividends, income statement impact for the quarter ending 2013-09-30 was $0.00.
- CervoMed Inc. preferred stock dividends, income statement impact for the quarter ending 2013-06-30 was $47.25K.
- CervoMed Inc. preferred stock dividends, income statement impact for fiscal 2013 was $171.63K.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $8.17M 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | $8.17M 10-Q · filed 2018-08-10 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $0.00 derived: sum of 2 quarters · filed 2015-04-03 | $47.25K derived: sum of 3 quarters · filed 2015-04-03 | $171.63K 10-K · filed 2015-04-03 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $47.25K derived: sum of 2 quarters · filed 2014-11-12 | $171.63K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $47.25K 10-Q · filed 2014-08-14 | $171.63K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |